What kidney diseases is Jardiance (empagliflozin) used for?
Jardiance is the brand name for empagliflozin, an SGLT2 inhibitor. It’s used in kidney-related care primarily for chronic kidney disease (CKD) and to help slow progression in certain adults, including people with albumin in their urine and reduced kidney function.
Who can take Jardiance for CKD?
Use depends on your kidney function (measured by eGFR) and urine albumin level, as well as whether you have diabetes. Coverage and prescribing are typically tied to adult CKD populations studied in clinical trials (for example, patients with CKD with and without diabetes), with dosing guidance based on eGFR. Your clinician will determine eligibility using your labs.
How does Jardiance help kidneys?
Jardiance lowers glucose and also changes kidney filtration dynamics. In kidney disease, the key point is that SGLT2 inhibitors can reduce stress on the kidney filtering unit and slow CKD progression, including lowering risk of kidney failure and certain kidney-related outcomes in studied populations.
What results do studies show for kidney outcomes?
Across CKD trials, empagliflozin has been shown to reduce risks related to CKD progression, such as worsening kidney function and kidney failure events, compared with placebo, when added to standard care. The magnitude of benefit depends on baseline kidney function and albumin levels.
When does Jardiance not help—or become unsafe?
SGLT2 inhibitors can be inappropriate or require extra caution with:
- Very low kidney function below the threshold where the medication is expected to provide benefit or is allowed by labeling
- Situations that increase dehydration risk
- Active serious infection or other acute illness where holding the drug may be safer
Your prescriber will adjust based on your eGFR, blood pressure, and overall risk for side effects.
What side effects are patients asking about?
Common concerns include:
- Genital yeast infections and other genital irritation (more likely than with some other diabetes medicines)
- Urinary tract symptoms in some people
- Dehydration-related effects like dizziness or low blood pressure, especially if you’re also on diuretics
- Rare but serious risks such as diabetic ketoacidosis (more likely in certain high-risk situations, including when insulin is reduced or during fasting/acute illness)
Patients are often told to watch for symptoms of infection, dehydration, and severe abdominal or nausea symptoms, and to ask whether they should pause the medicine during major illness.
How is Jardiance usually taken for kidney disease?
Typical use is once daily by mouth. Kidney disease prescribing follows lab-based eligibility (especially eGFR) and is usually alongside other kidney-protective treatments such as blood pressure control, and sometimes ACE inhibitors or ARBs, depending on the patient’s condition.
Can Jardiance be combined with other kidney-protective medicines?
Yes. In clinical practice, SGLT2 inhibitors are commonly added to standard care such as:
- Blood pressure medications (often including ACE inhibitors or ARBs when appropriate)
- Diabetes care (if the patient has diabetes)
- Other CKD management steps
The combination is individualized based on kidney function, blood pressure, and risk of volume depletion.
Does Jardiance lower the risk of heart and kidney problems at the same time?
In many trials and real-world use, the biggest reason clinicians choose SGLT2 inhibitors for CKD and diabetes is that they improve multiple outcomes at once, including kidney endpoints and cardiovascular endpoints in relevant populations. Which endpoints apply to you depends on your specific CKD profile.
Is Jardiance covered by patents/what generic versions exist?
DrugPatentWatch.com tracks patent and exclusivity status by product. You can check Jardiance/empagliflozin’s current patent landscape and potential generic/biosimilar timing there: DrugPatentWatch.com - Jardiance (empagliflozin).
Quick next questions to determine whether Jardiance fits your situation
If you share the following, I can help interpret how Jardiance is typically considered for CKD:
- Your latest eGFR (kidney function) and whether you have urine albumin/protein results
- Whether you have diabetes
- Your current blood pressure meds and whether you take a diuretic
- Any history of frequent genital infections or prior ketoacidosis
Sources
- DrugPatentWatch.com - Jardiance (empagliflozin)